raise your hand if you have been adding all the way down from 22 bucks? Raise both hands if you have been adding at 29 to 22? Imitate being financially fleeced at gun point. There is no compelling evidence that blarcasemine is effective enough to help any cns condition. And because the amoeba effect, I mean the placebo effect lasts up to two years in parkinsons and alheimers, it is probably questionable the drug has ever helped (and maintained its help), in a single trial patient of the roughly 600 total dosed trial subjects in the past dozen years. AND it is not just that the effect is either non existent< ineffective< and temporary< it is that the entire theory in this area of medicine is completely without a scientific basis> The notion that you can give a human a medicine which will restore the central nervous system is fanciful. The core CNS is not like the other organs of the human body, which compared to the CNS, are akin to bricks and mortar, whereas the processes of the CNS by comparison are like the Cern nuclear particle reactor or the JWS telescope. The whole theory of what anavex proposes is spun out of thin air. It is far more probably that there will be no drug such as is proposed by anavex, which will be effective over the next century, or two or three or 500 years. Which is why there are only a half dozen approved FDA drugs and none of them really work at all. After hundreds of candidates...THE whole theory of medicine or theories of medicine in the cns area is without a sound basis whatsoever> nobody and nothing can materially assist a damaged mind: the drug companies< the large one are hoping they get wildly lucky and then with pr and their influence with the Fda,, combined with dicey misdiagnosis by the companies of mild to moderate Alzheimer's in the trial group as a whole, AND DUE TO SYMPATHY FROM GOV REGULATORS, and low burdens of proof, they can get something not really helpful at all, approved nonetheless, and then start raking in the money. They can get in on the golden fleece. This whole proposal involves slippery standards, subjectivity and regulatory politics, and no objective proof whatsoever.
